A Chinese family with progressive childhood cataracts and IVS3+1G>A CRYBA3/A1 mutations by Zhu, Yanan et al.
A Chinese family with progressive childhood cataracts and
IVS3+1G>A CRYBA3/A1 mutations
Yanan Zhu, Xingchao Shentu, Wei Wang, Jinyu Li, Chongfei Jin, Ke Yao
Eye Center of the 2nd Affiliated Hospital, Medical College of Zhejiang University, Hangzhou, China
Purpose: To characterize the disease-causing mutations in a Chinese family with progressive childhood cataracts.
Methods: Family history and clinical data were recorded. Direct gene sequencing together with multi-point linkage
analysis using microsatellite markers flanking the gene was applied to identify the disease-causing mutation.
Results: Lens examination in the affected members revealed childhood cataracts along with progressive developing fetal
nuclear lactescent cataracts with ‘Y’ sutural opacities, and also progressive developing peripheral cortical opacities. Direct
gene sequencing showed a G>A transition at the donor splice site of intron 3 (IVS3+1 G>A) of the βA1/A3-crystallin
gene (CRYBA3/A1) in this Chinese autosomal dominant childhood cataract family, and the maximum heterogeneity
logarithm of odds (HLOD) score obtained by multi-point analysis was detected at marker locus D17S1800 (HLOD=3.005;
α=1.000).
Conclusions: To our knowledge, this is the first report of a phenotype of progressive nuclear and cortical cataracts related
to the CRYBA3/A1 mutation IVS3+1 G>A. This finding expands the spectrum of cataract phenotypes caused by the IVS3+1
G>A mutation of CRYBA3/A1, confirms the phenotypic heterogeneity of this mutation and suggests the mechanism that
influences the cataractogenesis in different ethnic backgrounds.
Childhood cataracts are a cause of childhood blindness
worldwide. This disease accounts for more than 1 million
blind  children  in  Asia  and  about  10%  of  the  childhood
blindness  worldwide  [1].  Childhood  cataracts  are  also  a
clinically and genetically heterogeneous disorder in which the
phenotype varies considerably between and within families
[2]. From an etiological point of view, genetic mutation might
be the most common cause, especially for bilateral cataracts.
All three forms of Mendelian inheritance have been observed,
and  the  most  frequently  seen  in  non-consanguineous
populations is autosomal dominant (AD) transmission. At
present,  over  26  out  of  the  39  mapped  loci  for  isolated
congenital or childhood cataracts have been associated with
mutations in specific genes [3]. Of the cataract families in
which the mutant gene is known, approximately half have
crystallin  mutations,  including  the  αA-crystallin  gene
(CRYAA),  αB-crystallin  (CRYAB),  CRYBA3/A1,  βA4-
crystallin  (CRYBA4),  βB1-crystallin  (CRYBB1),  βB2-
crystallin (CRYBB2), γC-crystallin (CRYGC), γD-crystallin
(CRYGD) and γS-crystallin (CRYGS) [3-10], approximately
one quarter have connexin mutations in Connexin 46 (GJA3)
and Connexin 50 (GJA8) [11,12], with the remainder being
divided among the genes for heat shock transcription factor-4
(HSF4)  [13],  aquaporin-0  (AQP0,  MIP)  [14,15],  beaded
filament  structural  protein-2  (BFSP2)  [16],  paired-like
homeodomain 3 (PITX3) [17], chromatin modifying protein
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4B (CHMP4B) [18], and EPH receptor A2 (EPHA2) [19].
Most of the mutations detected in these genes are missense
and  nonsense  mutations  [3].  Among  them,  CRYAA  [20],
CRYBA3/A1 [21], CRYBB2 [22], CRYGC [23], CRYGD [24],
GJA3 [25,26], GJA8 [26], BFSP2 [27], MIP [28], and HSF4
[29] have been reported to be related to nuclear cataracts.
The CRYBA3/A1 mutation was first identified as a cause
of cataracts in a pedigree with autosomal dominant zonular
cataracts [8]. To date, three mutations have been reported in
CRYBA3/A1, IVS3+1 G>C [30], IVS3+1 G>A [8,21,31], and
279delGAG [32,33]. IVS3+1 G>A has been observed only in
the  Indian,  Australian,  and  Chinese  populations.  In  the
Chinese population, this mutation is related to posterior polar
cataracts [34].
In  this  study,  we  identified  a  Chinese  family  with
CRYBA3/A1  IVS3+1  G>A  by  genetic  analysis.  To  our
knowledge, this is the first report to relate this mutation site
with  progressive  childhood  cataracts  characterized  by
opacities in the fetal nucleus and peripheral cortex.
METHODS
Family  data  and  genomic  DNA  preparation:  A  four-
generation  family  with  autosomal  dominant  childhood
cataracts was ascertained through the Eye Center of the 2nd
Affiliated Hospital, Medical College of Zhejiang University,
Hangzhou,  China,  and  this  study  was  approved  by  the
Zhejiang University Institutional Review Board. Appropriate
informed consent was obtained from all participants and the
study protocol followed the principles of the Declaration of
Helsinki. Seventeen individuals (9 affected and 8 unaffected)
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2347from the family took part in the study (Figure 1). The affected
status was determined by a history of cataract extraction or
ophthalmologic  examination,  including  visual  acuity,  slit
lamp,  and  fundus  examination.  The  phenotypes  were
documented by slit lamp photography.
Genomic DNA preparation: We collected blood specimens
(5 ml) in EDTA and extracted the genomic DNA from the
peripheral blood leukocytes of the available family members
using the Simgen Blood DNA mini kit (Simgen, Hangzhou,
China).
Mutation screening: We used the functional candidate gene
analysis approach. Gene specific PCR primers for CRYAA,
CRYBA3/A1, CRYBB1, CRYBB2, CRYGC, CRYGD, GJA3,
GJA8, and MIP were designed flanking each exon and intron-
exon  junction.  The  cycling  conditions  for  PCR  were  as
follows:  95  °C  preactivation  for  5  min,  10  cycles  of
touchdown PCR with 1 °C down per cycle from 60 °C to
50 °C, followed by 25 cycles with denaturation at 95 °C for
25 s, annealing at 55 °C for 25 s and extension at 72 °C for 40
s, then finally extension at 72 °C for 10 min. Each reaction
mix (25 µl) contained 50 ng of genomic DNA, 10× PCR
buffer,1.5 mM MgCl2, 0.2 mM dNTPs, 5 µmol each of sense
and  antisense  primers  (Table  1)  and  2.5U  of  Taq  DNA
polymerase  (Sangon  Biotech,  Shanghai,  China).  Thermal
cycling  was  performed  under  suitable  conditions  using  a
C1000TM 48 well thermal cycler (Bio-Rad, Hercules, CA).
PCR  products  were  isolated  by  electrophoresis  on  1.5%
agarose gels and sequenced using the BigDye Terminator
Cycle sequencing kit V 3.1(Applied Biosystems, Foster City,
CA)  on  an  Applied  Biosystems  PRISM  3730  Sequence
Analyzer, according to the manufacturer’s directions.
Genotyping:  We  performed  a  partial  genome  scan  in  the
vicinity of the CRYBA3/A1 locus, and chose the 10 fluorescent
short tandem repeat polymorphic markers for this locus which
are shown in Figure 1. Multiplex PCR was performed in a
20 μl reaction mixture containing 10 ng of genomic DNA,
Figure 1. Pedigree of the proband. The black symbols indicate individuals with a diagnosis of congenital cataract performed by genetic analysis.
The arrow indicates the proband. All of the members shown in this figure except I:1 and I:2 took part in this project. The haplotype markers
are shown at the left of each generation. The black and white bars depict the disease and non-disease associated haplotype, respectively.
Haplotype analysis identified the causative gene as being between D17S921 and D17S800 on 17p12–21.2.
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23480.3 mM of each dNTP, 0.1 μM each of forward and reverse
primers,  1  U  HotStarTaq  polymerase  (Qiagen,  Hilden,
Germany),  3.0  mM  MgCl2,  and  1×  HotStarTaq  buffer.
Samples were incubated in a thermocycler for 15 min at 95 °C
and 20 s at 94 °C; the annealing temperature was programmed
to initiate at 65 °C for 40 s and decrease 0.5 °C every cycle;
then 68 °C for 2 min, for 11 cycles; followed by 94 °C for 20
s, 59 °C for 40 s, 68 °C for 2 min, for 24 cycles; a final
extension at 60 °C for 1 h was performed. The PCR products
were appropriately pooled and an aliquot was loaded onto a
5% standard denaturing polyacrylamide gel and run in an
Applied Biosystems 3130xl Genetic Analyzer. The size of
each allele was determined on the basis of an internal size
standard  (GeneScanTM  −500  Liz  Size  Standard,  Applied
Biosystems) in each lane, and results were analyzed using the
Applied Biosystems GeneMapper 4.0.
Linkage  analysis  and  haplotyping:  Multi-point  linkage
analysis was calculated using Merlin. A gene frequency of
0.0001 and penetrance of 100% were assumed. Microsatellite
markers,  allele  frequencies,  and  recombination  distances
between  the  marker  loci  were  based  on  the  Marshfield
database and the UCSC database. Family and haplotype data
were processed using Cyrillic software (version 2.1; Cyrillic,
Oxfordshire, UK).
RESULTS
Clinical evaluation: We identified a four-generation Chinese
family  with  a  clear  diagnosis  of  autosomal  dominant
childhood cataracts. Most affected individuals noticed their
visual impairments before the age of twenty, and then their
visual acuity decreased gradually until surgery was required
to restore their visual function before the age of 40 (Figure 1).
Opacity  of  the  lens  was  bilateral  in  all  of  the  affected
individuals. The proband, who was a 28 year-old, had nuclear
lactescent  cataracts,  ‘Y’  sutural  opacities,  and  dot-like
peripheral cortical opacities. His clinical features were almost
the same as his brother (III:3). The affected member II:2, who
was the mother of the proband, had more severe, curd-like
cortical opacities, but her nuclear opacities were not much
different from those of her sons. In the childhood stage before
the age of ten, like IV:1, who was a 9 year-old, there was no
opacity in the peripheral cortex, but there were mild opacities
in the nucleus which had been first identified when he was
three years old (Figure 2). After the age of 10, like the case of
IV:2, who was a 12 year-old, certain fine, sand like opacities
developed. The clinical evaluation of the affected individuals
is provided in Table 2. Before surgery, the affected members
had a visual acuity which ranged from finger counting to
20/100. After surgery, all the patients achieved a distance
visual acuity of 20/25 to 20/20. There was no family history
of other ocular or systemic abnormalities.
Genetic analysis: Through gene sequencing we identified a
single base substitution in the donor splice site of intron 3 in
CRYBA3/A1  (IVS3+1  G>A)  which  cosegregated  with  all
affected individuals, whereas this heterozygous mutation was
not present in the unaffected family members, and also 100
unrelated  Chinese  without  cataracts  serving  as  a  control
(Figure 3).
Linkage  and  haplotype  analysis:  Genescan  and  linkage
analysis were carried out by using 10 microsatellite markers
flanking  the  CRYBA3/A1  gene,  and  positive  results  were
obtained,  including  the  maximum  HLOD  score  3.005  at
D17S1800 (α=1.000; Table 3). Haplotype analysis showed
that the affected individuals in the family shared a common
haplotype, with a region flanked by the markers D17S921 and
D17S800 at 17p12–21.2 containing CRYBA3/A1.
DISCUSSION
The  genes  which  are  reported  to  cause  cataract-specific
mutations  include  those  of  the  crystallins,  cytoskeletal
proteins,  membrane  proteins,  transcription  factors,  and
chromatin modifying protein-4B [35]. Among the reported
genes,  the  crystallins  are  of  special  interest  because  they
encode  the  major  proportion  of  water  soluble  structural
proteins of the lens fiber cells. The human lens contains α-,
TABLE 1. PRIMERS USED IN POLYMERASE CHAIN REACTION OF CRYBA3/A1.
Name Prime Sequence(5′-3′) Product length (bp)
Exon1F AGCAAGCTGAGCCACCAAAG 308
Exon1R GCTGTCTTCCGCCAGAGTTC  
Exon2F TCGTGTGTGCTCTGTCTTCC 205
Exon2R CCCCTACAAACTGGGGTTTT  
Exon3F CATCAGGCATCCCAGGCTACA 333
Exon3R TCCTTCTTCCCCTATCCCCAC  
Exon4F CGTCAACTCATTCCTCAACTCT 464
Exon4R CAGGCTTAGAGAAGAAAGTGATGT  
Exon5F TTTCTCACAAATCTGTTGCCTTA 340
Exon5R CAAAGTAACTCCTGAGGTTGCA  
Exon6F AGGCTCAGGTTTTGGGGTAT 471
Exon6R ACTCCAGCCTGAGCAACAAG  
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2349β-, and γ-crystallins, of which the β-crystallins comprise the
greatest part.
Thus far, three identified mutations in CRYBA3/A1 gene
have  been  associated  with  autosomal  dominant  cataract
phenotypes of either a congenital or childhood nature. One is
the  IVS3+1  G>A  mutation  (position  474,  GenBank
M14303) which we reported [8,21,31], another is IVS3+1
G>C [30], and a third is a 3-bp deletion at positions 279–281
in exon 4 (279delGAG) [32,33]. Furthermore, the mutation
IVS3+1  G>A  has  been  found  in  5  additional  families.
Kannabiran et al. [8] reported an Indian pedigree in which the
phenotype  was  zonular  cataracts  with  sutural  opacities,
Another two Indian pedigrees were reported by Devi et al.
[31] with the phenotype of zonular lamellar opacities. An
Australian family was reported by Burdon et al. [21] having
the clinical features of Y-sutural opacities, mild opacification
throughout the region of the fetal nucleus, and peripheral
cortical dot opacities, and Gu et al. [34] identified a Chinese
family with posterior polar cataracts, which was the first time
this mutation was found in the Chinese population. Although
the nuclear, sutural, and cortical cataracts were also found in
the Australian family, the clinical features we observed were
still distinctly different. First, in the family we studied, the
nuclear cataracts in the affected individuals are progressive.
Figure 2. Photographs of the eyes of the family members with congenital cataracts. A: The left eye of proband III:5. Diffuse illumination
shows a fetal nuclear lactescent cataract with ‘Y’ sutural opacities and mild peripheral cortical opacities. B: Retroillumination showing the
left eye of proband III:5. C: The right eye of II:2. Diffuse illumination shows denser peripheral cortical opacities, but the opacity of nucleus
is almost the same as III:5. D: Retroillumination showing the right eye of proband II:2. E: The left eye of IV:1. Diffuse illumination shows
only mild nuclear and sutural opacities. F: Retroillumination showing the left eye of proband IV:1.





Age at cataract surgery Phenotype
II:2 55 55 Nuclear lactescent cataract, ‘Y’ sutural opacities, severe curd-like peripheral
cortical opacities
II:4 48 36 Had cataract surgery 12 years ago
II:6 45 35 Had cataract surgery 10 years ago
III:1 35 30 Had cataract surgery 5 years ago
III:3 33 28 Nuclear lactescent cataract, ‘Y’ sutural opacities, fine sand-like peripheral
cortical opacities
III:5 28 28 Nuclear lactescent cataract, ‘Y’ sutural opacities, fine sand-like peripheral
cortical opacities
III:6 25 22 Had cataract surgery 3 years ago
IV:1 9 No surgery Mild nuclear opacities with sutural opacities
IV:2 12 No surgery Nuclear opacities with sutural opacities, a few dot-like cortical opacities
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2350Mild nuclear opacities with sutural opacities first appear at
approximately 3 years of age, and progress thereafter. After
20 years of age, the nuclear opacities deteriorate so as to
become  lactescent,  and  thus  become  the  main  factor
influencing the visual acuity. Second, the cortical cataracts in
our case are also progressive. The fine, sand-like peripheral
cortical opacities are observed just after 10 years of age, and
progress with a trend of increasing and aggregating. After the
age of 50 years they are almost curd-like. Fortunately, these
cataracts in childhood are so mild that they exert little negative
effect on visual development. After surgery, all of the patients
achieved good visual acuity.
The  related  gene  CRYBA3/A1  is  located  in  17q11.2
(GeneID:  1411),  which  is  a  member  of  crystallin  family,
encoding two proteins (βA3-crystallin and βA1-crystallin)
from a single mRNA. The latter protein is 17 amino acids
shorter than βA3-crystallin and is generated by use of an
alternate translation initiation site. Seven protein regions exist
in βA1/A3-crystallin: four homologous motifs, a connecting
peptide,  and  NH2-  and  COOH-terminal  extensions.  Each
motif  is  a  Greek  key  of  four  β-strands  and  consists  of
approximately 40 amino acid residues. The CRYBA3/A1 gene
consists of six exons [36]. In the CRYBA3/A1 gene, the four
Greek key motifs are approximately encoded by exons 3 to 6
[37]. Splice-site mutations were reported to result in exon
skipping,  activation  of  cryptic  splice  sites,  creation  of  a
pseudo-exon  within  an  intron,  or  intron  retention,  among
which exon skipping is the most frequent outcome [38]. The
Figure  3.  Partial  DNA  sequence  of
CRYBA3/A1 from one normal and one
affected  individual,  showing  a
heterozygous mutation (IVS3+1 G>A)
in  the  third  canonical  GT  site  of
CRYBA3/A1 (black triangles). The black
vertical line denotes the normal exon 3-
intron 3 donor splice site.
TABLE 3. MULTI-POINT LINKAGE ANALYSIS BETWEEN CHROMOSOME 17 DNA MARKERS.
Locus Position (CM) LOD α HLOD
D17S799 31.960 1.485 1.000 1.485
D17S900/921 36.140 −6.484 0.000 0.000
D17S805 47.000 3.003 1.000 3.003
D17S1800 51.630 3.005 1.000 3.005
D17S1293 56.480 3.003 1.000 3.003
D17S1836 60.400 2.459 1.000 2.459
D17S800 62.010 −6.780 0.000 0.000
D17S1861 63.620 −6.603 0.000 0.000
D17S1817 103.530 −17.703 0.000 0.000
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2351donor splice site of intron 3 of CRYBA3/A1 (position 474) is
the first nucleotide in the invariant GT dinucleotide of the 59
splice junction consensus sequence [30]. Due to the mutation
IVS3+1 G>A, as we previously reported, the very next codon
within the retained intron 3 would be a UGA stop site, which
mimics a missense mutation at the protein level. Although the
surveillance  of  mRNAs  for  transcripts  that  cannot  be
completely  translated  leads  to  their  rapid  degradation  by
nonsense-mediated  decay  (NMD)  [39],  transcripts  of  the
IVS3+1  G>A  of  CRYBA3/A1  probably  escape  the  NMD
pathway, and the premature termination codon (PTC) would
cause truncation of the βA1/A3-crystallin immediately after
the first motif. Since the Greek key motifs are formed with the
fourth strand of the first motif being provided by the second
motif and vice versa, without the second motif encoded by
exon 4, it would not be possible to form even a single Greek
key structure [40]. Due to the loss of exons 3 and 4 in CRYBA3/
A1 mRNA, a βA1/A3-crystallin species is suggested which
contains only the COOH-terminal globular domain [8]. Gupta
et al. [41] constructed eight deletion mutants of βA1/A3-
crystallin and found that the deletion of exon 3 and exon 4
caused  major  structural  instability,  leading  to  the
insolubilization of βA1/A3-crystallin. However there is as yet
insufficient  research  in  this  field,  and  the  nature  of  the
complex mechanism remains to be determined.
In conclusion, we have identified a progressive form of
congenital  cataracts  associated  with  the IVS3+1 G>A muta-
tion of CRYBA3/A1  in  a  Chinese  family.  This  is  the  first
report  to relate this  mutation to  progressive  cataracts. This
study  highlights  the  physiologic  importance of  βA1/A3-
crystallin  and  supports  the  role of  CRYBA3/A1  in  human
cataract formation.
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